DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 99 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,458,079 | +13.0% | 437,243 | -1.1% | 0.07% | +20.0% |
Q2 2023 | $5,713,960 | +32.6% | 442,257 | +0.7% | 0.06% | +27.9% |
Q1 2023 | $4,308,415 | +0.0% | 439,186 | +8.5% | 0.04% | -4.4% |
Q4 2022 | $4,307,561 | +28.5% | 404,846 | +26.1% | 0.04% | +18.4% |
Q3 2022 | $3,351,000 | -8.4% | 321,006 | +10.4% | 0.04% | 0.0% |
Q2 2022 | $3,659,000 | +15.3% | 290,650 | -0.7% | 0.04% | +40.7% |
Q1 2022 | $3,174,000 | -22.8% | 292,833 | +0.1% | 0.03% | -12.9% |
Q4 2021 | $4,114,000 | -31.4% | 292,400 | -6.4% | 0.03% | -31.1% |
Q3 2021 | $6,001,000 | +57.5% | 312,400 | -19.2% | 0.04% | +73.1% |
Q2 2021 | $3,810,000 | +0.2% | 386,800 | 0.0% | 0.03% | 0.0% |
Q1 2021 | $3,802,000 | +120.9% | 386,800 | 0.0% | 0.03% | +85.7% |
Q4 2020 | $1,721,000 | +3.0% | 386,800 | 0.0% | 0.01% | -22.2% |
Q3 2020 | $1,671,000 | -51.3% | 386,800 | 0.0% | 0.02% | -52.6% |
Q2 2020 | $3,431,000 | +132.0% | 386,800 | -7.7% | 0.04% | +90.0% |
Q1 2020 | $1,479,000 | -14.0% | 418,900 | +39.4% | 0.02% | +33.3% |
Q4 2019 | $1,719,000 | +65.4% | 300,500 | +3.4% | 0.02% | +50.0% |
Q3 2019 | $1,039,000 | +94.9% | 290,500 | +117.3% | 0.01% | +100.0% |
Q2 2019 | $533,000 | -66.7% | 133,700 | -39.0% | 0.01% | -64.3% |
Q1 2019 | $1,602,000 | -20.1% | 219,100 | 0.0% | 0.01% | -22.2% |
Q4 2018 | $2,005,000 | +357.8% | 219,100 | +97.4% | 0.02% | +500.0% |
Q4 2016 | $438,000 | -65.2% | 111,000 | -7.5% | 0.00% | -62.5% |
Q3 2016 | $1,259,000 | -47.3% | 120,000 | -26.8% | 0.01% | -50.0% |
Q2 2016 | $2,391,000 | -58.4% | 164,000 | -45.2% | 0.02% | -55.6% |
Q1 2016 | $5,753,000 | +13.9% | 299,000 | +43.1% | 0.04% | +20.0% |
Q4 2015 | $5,049,000 | -35.5% | 209,000 | -34.5% | 0.03% | -28.6% |
Q3 2015 | $7,828,000 | +44.0% | 319,000 | +37.5% | 0.04% | +82.6% |
Q2 2015 | $5,435,000 | -6.8% | 232,000 | -10.8% | 0.02% | +4.5% |
Q1 2015 | $5,832,000 | – | 260,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |